Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer [Phase 2]
A Phase 2 trial sponsored by Mayo Clinic compares at-home cancer-directed therapy to in-clinic treatment for patients with various advanced …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma [EARLY_Phase 1]
An early-phase clinical trial evaluating YSCH-01 as monotherapy and in combination with atezolizumab for recurrent glioblastoma, focusing on…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma [Phase 1]
Phase 1 study of RMC-5552 as monotherapy in adults with recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 2]
A Phase 2 clinical trial update exploring whether peripheral blood immunologic biomarkers predict response to adjuvant immune checkpoint inh…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO] [NA]
This clinical trial investigates applying FET-PET imaging fused with MRI to guide treatment in glioblastoma and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM [Phase 1]
Phase 1 clinical trial update on a personalized neoantigen cancer vaccine with radiotherapy and pembrolizumab for newly diagnosed glioblasto…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma [Phase 1]
This clinical trial investigates temozolomide (Temodar) in combination with the HDAC inhibitor Abexinostat for recurrent high-grade gliomas,…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: AB154 Combined With AB122 for Recurrent Glioblastoma [EARLY_Phase 1]
A phase 1 trial evaluating AB154 in combination with AB122 for recurrent Glioblastoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
This clinical trial update summarizes the safety and feasibility findings of using ExAblate focused ultrasound to disrupt the blood-brain ba…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery [NA]
A clinical trial is testing a new fluid to improve ultrasound image quality during brain tumor surgery and is currently recruiting. Sponsor:…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma [Phase 3]
An ongoing Phase 3 clinical trial is evaluating TLX101-Tx plus standard of care vs standard of care alone in patients with recurrent gliobla…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma [Phase 1]
This Phase 1 trial tested adding a ketogenic diet to standard radiotherapy and temozolomide in glioblastoma and has completed.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR [EARLY_Phase 1]
This early-phase study is evaluating tumor oxygenation, metabolism, and blood supply in high-grade glioma and cervical cancer using Dynamic …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas
This clinical trial update describes a study using APT-weighted and diffusion MRI to characterize tumor infiltration in high-grade gliomas. …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme [Phase 2]
This is an update on a Phase 2 clinical trial evaluating Berubicin in adults with glioblastoma, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their Partners [NA]
This clinical trial at MD Anderson Cancer Center is evaluating a couples-based yoga program to improve quality of life for patients with hig…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/Phase 2 study evaluating the combination of durvalumab with hypofractionated …
-
CLINICAL_TRIALS withdrawal · 2026-04-14Clinical Trial Update: Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma [Phase 3]
Phase III trial evaluating two brain conformational radiotherapy regimens in combination with chemotherapy for Glioblastoma has been termina…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study [NA]
Completed proof-of-concept clinical trial evaluating the ability of MRI spectroscopy to delineate tumor areas enriched for glioblastoma stem…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lutathera (177Lu-DOTATATE) in combination with Olaparib for somatostatin receptor–expressing recurrent…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and tolerability of MT-125 in patients with glioblastoma. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening [NA]
A clinical trial update describes a study on personalized targeted therapies for glioblastoma using ex vivo drug screening, conducted by the…
-
CLINICAL_TRIALS other · 2026-04-14Clinical Trial Update: Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII [Phase 2]
A Phase 2 clinical trial evaluating silevertinib in combination with temozolomide for newly diagnosed glioblastoma with unmethylated MGMT an…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the addition of selinexor to temozolomide for recurrent glioblastoma, including MGMT-methylated and…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma [Phase 1, Phase 2]
An update on a Phase 1/2 clinical trial evaluating ultrasound-induced opening of the blood-brain barrier in combination with albumin-bound p…